Evaluation of the quality of life in patients with multiple sclerosis
Keywords:multiple sclerosis, quality of life, disability, depression, anxiety, stress
AbstractMultiple sclerosis (MS) is the best known and widespread demyelinating disease of the nervous system. About 3 million people suffer from MS in the world (about 0.5–1 ‰) and about 20,000 in Ukraine. It is among the “four horsemen of the neurological apocalypse” due to its medical and social implications. The disease ranks second among the disabled patients of working age and is accompanied by the acute neuropsychological changes, which manifest themselves in the abnormal behavior. The use of drugs of pathogenetic and symptomatic therapy, including the remedies that slow the progression of the disease, allows increasing the life expectancy of most patients with MS. However, there are several non-motor factors that change during the course of the disease, modifying the patient’s self-perception, professional, and social qualities. Such people are often prone to depression and anxiety, they are emotionally unstable and prone to frequent and sudden mood swings. An integral indicator of the physical, psychological, emotional, and social functioning of a patient with MS is the quality of life. The research provides an evaluation of the quality of life in MS patients with disability.
Ulitsky L.A., Chukhlovina M.L. Diagnosis of nervous diseases. 2001. P. 372.
Chuprina G.M. Multiple sclerosis: etiology, pathogenesis, clinic, diagnostics, differential diagnosis, treatment (clinical lecture). Eastern European Neurological Journal. 2017. 5. P. 27-37.
Sokolova L.I. Multiple sclerosis: key signs and treatments. III International Conference: Advances in Neurology. April 11–13, 2019.
Sharov D.A. Integral assessment of quality of life of patients with multiple sclerosis. Neuroimmunology. 2009. 1. P. 105-106.
Schwartz C.E., Foley F.W., Rao S.M., Bernardin L.J., Lee H., Genderson M.W. Stress and Course of Disease in Multiple Sclerosis. Behavioral Medicine. 1999. 25. 3. P. 110-116. doi: 10.1080/08964289909596740.
Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of the neurological sciences. 2002. 205 (1). P. 51-58.
Beiske A.G., Svensson E., Sandanger I., Czujko B., Pedersen E.D., Aarseth J.H., Myhr K.M. Depression and Anxiety amongst Multiple Sclerosis Patients. European Journal of Neurology. 2008. 15. P. 239-245. doi: 10.1111/j.1468-1331.2007.02041.x.
Masaaki Niino, Yusei Miyazaki. Cognitive impairment as one of the important nonmotor symptoms in multiple sclerosis and neuromyelitis optica spectrum disorders. Clinical and Experimental Neuroimmunology. 2019. Vol. 10, Issue 3. doi: 10.1111/cen3.12528.
Beiske A.G. Non-motor symptoms in multiple sclerosis. Doctoral thesis, University of Oslo, 2009.
Gusev E.I., Boyko A.N. Multiple sclerosis: achievements of the decade. Journal of Neurology and Psychiatry. 2007. 4. P. 4-14.
Schmidt T.E. Pathogenetic treatment of multiple sclerosis. Medical Council. 2010. 9–10. P. 74-79.
Copyright (c) 2020 INTERNATIONAL NEUROLOGICAL JOURNAL
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.